Category: by author

ORI-sanctioned former UT-Southwestern cancer researchers up to 10 retractions

CLThere’s been a 10th retraction from two former postdocs at a UT-Southwestern cancer research center who were sanctioned by the Office of Research Integrity (ORI) last September, in part due to observations and comments from Retraction Watch readers.

It’s a 2008 Cancer Letters paper, “Methylation of apoptosis related genes in the pathogenesis and prognosis of prostate cancer,” retracted at the request of Makoto Suzuki, the first author who has claimed responsibility for falsifying data in this and five other papers. Continue reading ORI-sanctioned former UT-Southwestern cancer researchers up to 10 retractions

Retraction-plagued management researcher hit with expression of concern

OrgBehav_ak13The editor-in-chief of Organizational Behavior and Human Decision Processes has issued an Expression of Concern about a 2011 paper that explores the link between ethical leadership and employee performance.

The paper, “Linking ethical leadership to employee performance: The roles of leader–member exchange, self-efficacy, and organizational identification,” is one of seven that were flagged in a report by Arizona State University (ASU) that investigated the corresponding author, Frederick Walumbwa, for possible research misconduct, as we noted in November.

“The fit statistics reported in the article contain many errors,” the notice says. It goes on to say that “it is difficult to understand the implications of these errors unless the raw data is made available” — but that the authors were not able to provide it. Here’s the full text of the expression of concern: Continue reading Retraction-plagued management researcher hit with expression of concern

Third retraction for GWU biologist as university seeks to dismiss his $8 million lawsuit

Rakesh Kumar, via George Washington University
Rakesh Kumar, via George Washington University

Cancer biologist Rakesh Kumar has chalked up another retraction, this time for “identical,” “duplicated,” and “replicated” figures and images.

It comes on the heels of a flurry of motions in Kumar’s $8 million lawsuit against his employer, George Washington University, for breach of contract and emotional distress because it removed him as department chair last year and placed his research on hold. Kumar remains employed by the university.

The retracted paper, published in Development in 2004, “Metastasis-associated protein 1 deregulation causes inappropriate mammary gland development and tumorigenesis,” analyzed the role of a protein, MTA1, in mammary gland development and cancer. It was published while Kumar was at M.D. Anderson in Houston, and has been cited 81 times, according to Thomson Scientific’s Web of Knowledge.

By our count, Kumar now has three retractions and five corrections. Numerous anonymous comments on Kumar’s papers have been posted on PubPeer, many of them critiquing images. Here’s the complete notice from Development: Continue reading Third retraction for GWU biologist as university seeks to dismiss his $8 million lawsuit

Malpractice case against Duke, Anil Potti settled

pottiA lawsuit filed in October 2011 against Duke University and Anil Potti, who has retracted 11 papers and corrected a number of others amidst investigation into his work, has been settled, Retraction Watch has learned.

Potti resigned from Duke in 2010 following questions about his work, and revelations that he had lied on grant applications about being awarded a Rhodes Scholarship. He now works at a cancer center in North Dakota.

The lawsuit was filed by subjects in clinical trials based on Potti’s work. Plaintiff’s attorney Thomas W. Henson, who confirmed the settlement, tells Retraction Watch: Continue reading Malpractice case against Duke, Anil Potti settled

Former Florida ob-gyn prof notches eighth retraction

University of Florida
University of Florida

Nasser Chegini, the former University of Florida professor currently under investigation by the Office of Research Integrity (ORI), has now had eight papers retracted.

The eighth paper, in the journal Reproductive Biology and Endocrinology, is about the effect of a compound used during fertility treatments on Smads, signaling molecules that carry messages from TGF-beta receptors to the nucleus. It’s being retracted disappeared due to the discovery of data that “have been fabricated or falsified by the last author” — namely, Chegini.

Here’s more from the notice for “Gonadotropin releasing hormone analogue (GnRHa) alters the expression and activation of Smad in human endometrial epithelial and stromal cells:” Continue reading Former Florida ob-gyn prof notches eighth retraction

Bielawski and Wiggins retraction count grows to six

chemical scienceA group of chemists whose work was investigated by the University of Texas-Austin has had another paper retracted, this one of a Chemical Science study previously subjected to an Expression of Concern.

That makes six retractions for Christopher Bielawski and Kelly Wiggins.

Here’s the notice for “Homonuclear bond activation using a stable N,N′-diamidocarbene”, signed by all three authors of the paper: Continue reading Bielawski and Wiggins retraction count grows to six

Beleaguered Förster turns down prestigious professorship, citing personal toll

forster-j-a1
Jens Förster

Jens Förster, a social scientist accused of research misconduct, has turned down a highly coveted — and well-endowed — professorship from the Alexander von Humboldt Foundation.

Foster explained his decision to decline the 5 million Euro award in a post on his personal website: Continue reading Beleaguered Förster turns down prestigious professorship, citing personal toll

Gynecologic cancer researcher earns eighth retraction

Screen Shot 2015-04-02 at 5.50.31 PMNoriyuki Takai, a gynecologic cancer researcher in Japan, has notched one more retraction — bringing the total to eight — due to figures that were “processed inappropriately” and did “not accurately report the original data.”

According to the notice, Takai alone put the figures together in the 2006 Oncology paper, which tested a histone deacetylase inhibitor on endometrial and ovarian cancer cell lines. The team is part of the department of obstetrics and gynecology at Oita University in Japan.

Takai lost four papers in 2013 in Cancer Letters, and three papers in 2012 in Gynecologic Oncology, also due to issues with figures.

Continue reading Gynecologic cancer researcher earns eighth retraction

“Super-surgeon” Macchiarini not guilty of misconduct, per one Karolinska investigation

Paolo Macchiarini
Paolo Macchiarini

Surgeon Paolo Macchiarini, who is under investigation for allegedly downplaying dangers of an experimental surgery, has been cleared of some misconduct allegations by the Karolinska Institutet in Stockholm.

Macchiarini, a thoracic surgeon, has made headlines for repairing damaged airways using tracheas from cadavers and even synthetic tracheas, both treated with the patients’ own stem cells to assist in the transplant.

In a letter to Vice-Chancellor Anders Hamsten dated last month, KI’s Ethics Council refuted a number of accusations leveled against Macchiarini by Pierre Delaere at KU Leuven in Belgium, who had suggested the surgeon had engaged in scientific misconduct, including fabricating data.

The Ethics Council, however, disagreed:

Continue reading “Super-surgeon” Macchiarini not guilty of misconduct, per one Karolinska investigation

Investigations into Voinnet’s work announced; critic publishes original peer review

Olivier Voinnet
Olivier Voinnet

The story about Olivier Voinnet, a high-profile plant biologist whose work has fallen under scrutiny, continues to build momentum. Late last week, Voinnet’s employer and one of his funders announced they were investigating his work, and one of the peer reviewers of a soon-to-be-retracted paper has made her original report public.

Here’s the statement from CNRS, which funds Voinnet: Continue reading Investigations into Voinnet’s work announced; critic publishes original peer review